At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Combined Single Dose Study Under Fasting Condition And Multiple Doses Study Under Normal Diabetic Meal Comparing the Bioavailability of Two Formulations of 500 mg Metformin Hydrochloride Extended Release Tablets.
In Brief
A clinical study evaluating 500 mg metformin hydrochloride extended release caplet (test drug) and 500 mg metformin hydrochloride prolonged release tablet (reference drug) for Metformin XR BE Study in Healthy Volunteers With Single and Multiple Dose. Completed, enrolled 38 participants across 1 site.
Detailed Summary
This was a single centre, single-blind, randomized, balanced, combined single dose study under fasting condition and multiple doses study under fed condition with normal diabetic-meal, two-period, two-sequence cross-over study to to compare the bioavailability of metformin hydrochloride 500 mg extended release caplet (test drug) and metformin hydrochloride 500 mg prolonged release tablet (reference formulation).
Study Details
Timeline
Interventions
In each of the two study periods (separated by a washout of one week) a single and multiple dose of test or reference product was administered.
In each of the two study periods (separated by a washout of one week) a single and multiple dose of test or reference product was administered.